Video

Dr. Blay on the Heterogeneity of Soft Tissue Sarcoma

Jean-Yves Blay, MD, PhD, professor of Medicine at the Université Claude Bernard, Lyon, France, and the scientific director of the Canceropole Lyon Rhône Alpes, discusses the heterogeneity of soft tissue sarcoma.

Jean-Yves Blay, MD, PhD, professor of Medicine at the Université Claude Bernard, Lyon, France, and the scientific director of the Canceropole Lyon Rhône Alpes, discusses the heterogeneity of soft tissue sarcoma.

There are more than 80 different histological subtypes of sarcomas, and they have not all yet been explored, Blay explains. This will be a major part of research in the field going forward. Additionally, sarcoma remains to be a be a very difficult-to-treat patient population because it is not a homogenous group of tumors.

Clinical presentation, molecular behavior, and histology are all very different from one another in each of these sarcoma subtypes. These subgroups are also very rare, he adds.

Related Videos
Howard S. Hochster, MD, FACP,
John H. Strickler, MD
Brandon G. Smaglo, MD, FACP
Cedric Pobel, MD
Ruth M. O’Regan, MD
Michael R. Grunwald, MD, FACP
Peter Forsyth, MD
John N. Allan, MD
Dr Dorritie on the Clinical Implications of the 5-Year Follow-Up Data From CAPTIVATE in CLL/SLL
Minoo Battiwalla, MD, MS